LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Scott Weiner will speak about Pappas Ventures' perspective on the Medtech market at the IN3 West: Investment in Innovation Conference in Las Vegas, NV.
News | 02. 22. 2011
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.